Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...

F or those of us who have not yet participated in a clinical trial, it may feel like unfamiliar territory. However, ...

This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of ...

Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

"The patient experience is critical in thinking about how you design studies and how clinical trials are ultimately executed. Clinical trial participation can be very tough on patients. We need to put ...

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

The Pediatric Clinical Trials Office at Children’s of Alabama is helping lead the way in finding the best treatments for ...

Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...